Skip to content

Ethchlorvynol

NERVOUS SYSTEM

Also known as: alvinol, arvynol

OfmFDA approvedATC N05CM08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ethchlorvynol is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1961. DrugCentral lists 1 molecular target, including GABRA1|GABRG2|GABRB3. Recorded indications include Insomnia and Severe Insomnia.

  • Approval status: ofm (first approved 1961 by the FDA).
  • Molecular targets: GABRA1|GABRG2|GABRB3 (1 listed in DrugCentral).
  • Indications: Insomnia and Severe Insomnia.
  • ATC code: N05CM08 (Other hypnotics and sedatives).
  • Molecular formula: C7H9ClO; molecular weight 144.60 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Insomnia
  • Severe Insomnia

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
GABA-A receptor alpha-1/beta-3/gamma-2GABRA1|GABRG2|GABRB3other—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1961-05-10FDA—ABBVIE

ATC classification

ATC codeTherapeutic hierarchy
N05CM08NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Other hypnotics and sedatives

Chemical structure

Molecular formulaC7H9ClO
Molecular weight144.60 g/mol
CAS number113-18-8
InChIKeyZEHYJZXQEQOSON-UHFFFAOYSA-N
PubChem CID5281077
CCC(O)(C=CCl)C#C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ethchlorvynol used for?

DrugCentral lists the following indications for Ethchlorvynol: Insomnia and Severe Insomnia.

How does Ethchlorvynol work?

Its molecular targets in DrugCentral include GABRA1|GABRG2|GABRB3.

When was Ethchlorvynol first approved?

Ethchlorvynol was first approved by the FDA in 1961.

What is the chemical formula of Ethchlorvynol?

Ethchlorvynol has the molecular formula C7H9ClO and a molecular weight of 144.60 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1961-05-10
AgencyFDA
Targets1
Indications2
FormulaC7H9ClO
DrugCentral ID1078
Interactive profile